Details

Autor(en) / Beteiligte

• Berry, Gerald J., MD
• Burke, Margaret M., FRCPath
• Andersen, Claus, MD
• Bruneval, Patrick, MD
• Fedrigo, Marny, MD, PhD
• Fishbein, Michael C., MD
• Goddard, Martin, MD
• Hammond, Elizabeth H., MD
• Leone, Ornella, MD
• Marboe, Charles, MD
• Miller, Dylan, MD
• Neil, Desley, MD
• Rassl, Doris, MD
• Revelo, Monica P., MD
• Rice, Alexandra, FRCPath
• Rene Rodriguez, E., MD
• Stewart, Susan, FRCPath
• Tan, Carmela D., MD
• Winters, Gayle L., MD
• West, Lori, MD
• Mehra, Mandeep R., MD
• Angelini, Annalisa, MD

Titel

The 2013 International Society for Heart and Lung Transplantation Working Formulation for the standardization of nomenclature in the pathologic diagnosis of antibody-mediated rejection in heart transplantation

Ist Teil von

• The Journal of heart and lung transplantation, 2013-12, Vol.32 (12), p.1147-1162

Ort / Verlag

United States: Elsevier Inc

Erscheinungsjahr

2013

Link zum Volltext

Quelle

MEDLINE

Beschreibungen/Notizen

• During the last 25 years, antibody-mediated rejection of the cardiac allograft has evolved from a relatively obscure concept to a recognized clinical complication in the management of heart transplant patients. Herein we report the consensus findings from a series of meetings held between 2010-2012 to develop a Working Formulation for the pathologic diagnosis, grading, and reporting of cardiac antibody-mediated rejection. The diagnostic criteria for its morphologic and immunopathologic components are enumerated, illustrated, and described in detail. Numerous challenges and unresolved clinical, immunologic, and pathologic questions remain to which a Working Formulation may facilitate answers.